Rankings
▼
Calendar
AMRN Q3 2021 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$335M
Q3 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$142M
-9.2% YoY
Gross Profit
$112M
78.7% margin
Operating Income
-$13M
-9.2% margin
Net Income
-$13M
-9.3% margin
EPS (Diluted)
$-0.66
QoQ Revenue Growth
-8.1%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$1.0B
Total Liabilities
$393M
Stockholders' Equity
$642M
Cash & Equivalents
$223M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$142M
$156M
-9.2%
Gross Profit
$112M
$123M
-9.4%
Operating Income
-$13M
-$7M
-88.4%
Net Income
-$13M
-$7M
-93.7%
Revenue Segments
Product
$141M
100%
Licensing And Royalty
$596,000
0%
← FY 2021
All Quarters
Q4 2021 →